Investigating the Effect of Cyclodextrin Nanosponges and Cyclodextrin-Based Hydrophilic Polymers on the Chemical Pharmaceutical and Toxicological Profile of Al(III) and Ga(III) Complexes with 5-Hydroxyflavone
Source abstract
Abstract
In the present study, the complexes of aluminum and gallium with 5-hydroxyflavone were evaluated for their interaction with cyclodextrin polymers, as well as for the pharmacological effect of their inclusion. The cyclodextrin polymers were synthesized using diphenylcarbonate as a crosslinking agent, resulting in a lipophilic nanosponge (DPCNS), and pyromellitic dianhydride, resulting in a hydrophilic polymer (PMDACD). The inclusion complexes were synthesized and characterized via IR spectrometry and thermal analysis. The effect on the solubility of the metal complexes was also studied, where the hydrophobic nanosponge did not lead to an increase in solubility, but on the contrary, in the case of Al, it decreased; meanwhile, in the case of the hydrophilic polymer, the solubility of the metal complexes increased with the amount of polymer added. The cytostatic effect of inclusion complexes was investigated on two cell lines with different localizations, human colon adenocarcinoma (LoVo) and human ovarian adenocarcinoma (SKOV-3). The cytostatic efficacy is increased compared to simple complexes with efficacy on LoVo cells. Compared between the two metals, gallium complexes proved to be more active, with the efficacy of gallium complexes with the PMDACD being approximately the same as that of cisplatin, an antitumor agent used in therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Nigella sativa pharmacological applications · Aluminum toxicity and tolerance in plants and animals
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of General and Inorganic Chemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia, 020956 Bucharest, Romania
Department of Analytical Chemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia, 020956 Bucharest, Romania
Stefan S. Nicolau Institute of Virology, 285 Mihai Bravu Street, 030304 Bucharest, Romania
References (53)
Show source-provided references
1. Microbial Metabolism Part 9. 1. Structure and Antioxidant Significance of the Metabolites of 5,7-Dihydroxyflavone (Chrysin), and 5-and 6-Hydroxyflavones10.1248/cpb.56.418 ↗
2. Biosynthesis of flavonoids and effects of stress10.1016/S1369-5266(02)00256-X ↗
3. Hydroxyflavone metal complexes—Molecular structure, antioxidant activity and biological effects10.1016/j.cbi.2017.06.016 ↗
4. Antioxidant Properties of Hydroxy-Flavones10.1016/0891-5849(95)02014-4 ↗
5. Shamsudin, N.F., Ahmed, Q.U., Mahmood, S., Ali Shah, S.A., Khatib, A., Mukhtar, S., Alsharif, M.A., Parveen, H., and Zakaria, Z.A. (2022). Antibacterial Effects of Flavonoids and Their Structure-Activity Relationship Study: A Comparative Interpretation. Molecules, 27.10.3390/molecules27041149 ↗
6. Badshah, S.L., Faisal, S., Muhammad, A., Poulson, B.G., Emwas, A.H., and Jaremko, M. (2021). Antiviral activities of flavonoids. Biomed. Pharmacother., 140.10.1016/j.biopha.2021.111596 ↗
7. Anti-inflammatory effects of flavonoids10.1016/j.foodchem.2019.125124 ↗
8. Anti-inflammatory effects of flavonoids in neurodegenerative disorders10.1016/j.ejmech.2017.09.001 ↗
9. Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives
10. Flavonoids: Promising anticancer agents10.1002/med.10033 ↗
11. Neuroprotection by flavonoids10.1590/S0100-879X2003001200002 ↗
12. Hypolipidemic effect of flavonoids from mulberry leaves in triton WR-1339 induced hyperlipidemic mice
13. The antimutagenic activity of the major flavonoids of rooibos (Aspalathus linearis): Some dose-response effects on mutagen activation-flavonoid interactions10.1016/j.mrgentox.2007.03.009 ↗
14. Flavonoids and Immune Function in Human: A Systematic Review10.1080/10408398.2012.656770 ↗
15. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity10.1016/j.foodchem.2022.132531 ↗
16. An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge10.1016/j.toxrep.2022.03.011 ↗
17. Li, N., Shou, Z., Yang, S., Cheng, X., Chen, C., Zheng, S., Shi, Y., and Tang, H. (2023). Subtle distinction in molecular structure of flavonoids leads to vastly different coating efficiency and mechanism of metal-polyphenol networks with excellent antioxidant activities. Colloids. Surf. B Biointerfaces, 229.10.1016/j.colsurfb.2023.113454 ↗
18. Exudate Flavonoids of Primula spp: Structural and Biogenetic Chemodiversity
19. Chemodiversity of exudate flavonoids in Dionysia (Primulaceae): A comparative study10.1016/j.phytochem.2010.03.004 ↗
20. Structural and spectroscopic investigation of 5-hydroxyflavone and its complex with aluminium10.1016/S0022-2860(01)00433-1 ↗
21. Munteanu, A.C., Badea, M., Olar, R., Silvestro, L., Dulea, C., Negut, C.D., and Uivarosi, V. (2016). Synthesis and structural investigation of new bio-relevant complexes of lanthanides with 5-hydroxyflavone: DNA binding and protein interaction studies. Molecules, 21.10.3390/molecules21121737 ↗
22. Synthesis and characterization of some new complexes of magnesium (II) and zinc (II) with the natural flavonoid primuletin10.3390/molecules18077631 ↗
23. Radical scavenging propensity of Cu2+, Fe3+ complexes of flavonoids and in-vivo radical scavenging by Fe3+-primuletin10.1016/j.saa.2016.08.035 ↗
24. Vătavu, V.-N., Badea, M., Olar, R., Hudiță, A., Gălățeanu, B., Munteanu, A.C., and Uivarosi, V. (2019). Synthesis and Characterization of a New Cr(III) Complex with 5-Hydroxyflavone as a Potential Antidiabetic Agent. Proceedings, 29.10.3390/proceedings2019029118 ↗
25. A trinuclear oxo-chromium(III) complex containing the natural flavonoid primuletin: Synthesis, characterization, and antiradical properties10.3390/molecules20046310 ↗
26. Cytotoxicity studies, DNA interaction and protein binding of new Al (III), Ga (III) and In (III) complexes with 5-hydroxyflavone10.1002/aoc.4579 ↗
27. Antioxidant properties of complexes of flavonoids with metal ions10.1179/135100004225003897 ↗
28. Wang, H., Tan, M., Zhu, J., Pan, Y., Chen, Z., Liang, H., Liu, H., and Wang, H. (2009). Synthesis, cytotoxic activity, and DNA binding properties of copper (II) complexes with hesperetin, naringenin, and apigenin. Bioinorg. Chem. Appl., 2009.10.1155/2009/347872 ↗
29. Manganese-based complexes of radical scavengers as neuroprotective agents10.1016/S0968-0896(03)00070-1 ↗
30. Synthesis, spectroscopic characterization and in vitro antibacterial activity studies of Cu(II) complexes derived from 6- hydroxyflavone Schiff bases
31. Novel copper-based therapeutic agent for anti-inflammatory: Synthesis, characterization, and biochemical activities of copper(II) complexes of hydroxyflavone schiff bases10.1007/s12010-011-9529-z ↗
32. The in vitro antioxidant properties of the Al-quercetin/βCD and Al-catechin/βCD inclusion compounds, rationalized in terms of their electrochemical behaviour10.1007/s00044-011-9812-0 ↗
33. Deng, S.P., Yang, Y.L., Cheng, X.X., Li, W.R., and Cai, J.Y. (2019). Synthesis, spectroscopic study and radical scavenging activity of Kaempferol derivatives: Enhanced water solubility and antioxidant activity. Int. J. Mol. Sci., 20.10.3390/ijms20040975 ↗
34. Hoti, G., Lucia Appleton, S., Rubin Pedrazzo, A., Cecone, C., Matencio, A., Trotta, F., and Caldera, F. (2022). Strategies to Develop Cyclodextrin-Based Nanosponges for Smart Drug Delivery. Smart Drug Delivery, IntechOpen.10.5772/intechopen.100182 ↗
35. Cyclodextrin-based nanosponges as drug carriers10.3762/bjoc.8.235 ↗
36. Krabicová, I., Appleton, S.L., Tannous, M., Hoti, G., Caldera, F., Rubin Pedrazzo, A., Cecone, C., Cavalli, R., and Trotta, F. (2020). History of cyclodextrin nanosponges. Polymers, 12.10.3390/polym12051122 ↗
37. Cyclodextrin Nanosponges
38. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity10.1016/j.ejpb.2009.11.003 ↗
39. Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors10.1080/10717544.2017.1303856 ↗
40. Cyclodextrin nanosponges as potential anticancer drug delivery systems to be introduced into the market, compared with liposomes10.1016/j.jddst.2021.102931 ↗
41. Serrano-Martínez, A., Victoria-Montesinos, D., García-Muñoz, A.M., Hernández-Sánchez, P., Lucas-Abellán, C., and González-Louzao, R. (2023). A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment. Pharmaceutics, 15.10.3390/pharmaceutics15071824 ↗
42. Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity10.1016/j.ijpharm.2020.119356 ↗
43. Ordered and disordered cyclodextrin nanosponges with diverse physicochemical properties10.1039/C7RA00584A ↗
44. Phase-solubility techniques
45. Real-time analysis of quercetin, resveratrol and/or doxorubicin effects in mcf-7 cells
46. Ivan, B.-C., Barbuceanu, S.-F., Hotnog, C.M., Anghel, A.I., Ancuceanu, R.V., Mihaila, M.A., Brasoveanu, L.I., Shova, S., Draghici, C., and Olaru, O.T. (2022). New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation. Int. J. Mol. Sci., 23.10.3390/ijms23168854 ↗
47. Modulation of the interplay between p53, ICAM-1 and VEGF in drug-treated LoVo colon cancer cells10.25083/rbl/24.2/261.270 ↗
48. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer10.3233/CBM-190871 ↗
49. Saokham, P., Muankaew, C., Jansook, P., and Loftsson, T. (2018). Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes. Molecules, 23.10.3390/molecules23051161 ↗
50. Maciuca, A.-M., Munteanu, A.-C., Mihaila, M., Badea, M., Olar, R., Nitulescu, G.M., Munteanu, C.V.A., Bostan, M., and Uivarosi, V. (2020). Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies. Molecules, 25.10.3390/molecules25225418 ↗
51. Mihaila, M., Hotnog, C.M., Bostan, M., Munteanu, A.C., Vacaroiu, I.A., Brasoveanu, L.I., and Uivarosi, V. (2021). Anticancer Activity of Some Ruthenium(III) Complexes with Quinolone Antibiotics: In Vitro Cytotoxicity, Cell Cycle Modulation, and Apoptosis-Inducing Properties in LoVo Colon Cancer Cell Line. Appl. Sci., 11.10.3390/app11188594 ↗
52. Romani, A.M.P. (2022). Cisplatin in cancer treatment. Biochem. Pharmacol., 206.10.1016/j.bcp.2022.115323 ↗
53. Kregielewski, K., Fraczek, W., and Grodzik, M. (2023). Graphene Oxide Enhanced Cisplatin Cytotoxic Effect in Glioblastoma and Cervical Cancer. Molecules, 28.10.3390/molecules28176253 ↗